The inadequate biochemical control of acromegaly may be due to suboptimal dosing of medical therapies, poor compliance to treatments, resistance to drugs, tumor phenotype, inadequate monitoring, and uncertainty of GH and IGF-I assays (2). The gene discussed is GH1; the disease is acromegaly.